Ticker Details
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
IPO Date:	July 18, 2013
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 2.02%
Avg Daily Range (30 D):	$1.32 | 1.63%
Avg Daily Range (90 D):	$1.28 | 1.63%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.26M
Avg Daily Volume (90 D):	.29M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	2,580
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$3.15M
Avg Institutional Trade (90 D):	$3.39M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.69M
Avg Closing Trade (30 D):	$4.37M
Avg Closing Trade (90 D):	$4.49M
Avg Closing Volume:	41.94K

News

May 11, 2026 @ 9:09 PM Global Alpha Dumps 229,000 Ani Pharmaceuticals (AN... Source: Cory Renauer

Mar 27, 2026 @ 10:30 PM ANI Pharma Insider Sells 4,772 Shares as Revenue H... Source: Jonathan Ponciano

Feb 13, 2026 @ 11:50 AM ANI Pharmaceuticals to Discuss Fourth Quarter and ... Source: Na

Dec 28, 2025 @ 5:26 PM ANI Stock Is Up 49% This Past Year, Revenue Is Sur... Source: Jonathan Ponciano

Aug 29, 2025 @ 12:00 PM CG Oncology’s Executive Leadership to Parti... Source: Cg Oncology

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$4.11	$1.31	$1.24
Diluted EPS	$3.94	$1.28	$1.17
Revenue	$923.71M	$237.46M	$247.06M
Gross Profit
Net Income / Loss	$92.15M	$29.49M	$27.49M
Operating Income / Loss	$123.79M	$38.89M	$34.77M
Cost of Revenue
Net Cash Flow	$161.38M	$25.59M	$22.98M
PE Ratio

Splits
Jul 18, 2013	1:6
Jun 04, 2012	1:6
Jun 03, 2002	1:10